Patanjali Foods Q2 FY27: PAT falls 19% YoY to ₹420 Cr as margins compress, FMCG flat
PAT -18.77% YoY · revenue +15.55% · margins compressing
₹11,322.58 Cr
+15.55% YoY
₹419.77 Cr
-18.77% YoY
3.68%
-1.6pp YoY
₹3.86
Patanjali Foods' consolidated revenue rose 15.5% YoY to ₹11,322.58 Cr (from ₹9,798.84 Cr), but consolidated PAT fell 18.8% YoY to ₹419.77 Cr (from ₹516.70 Cr) as net profit margin compressed to 3.71% from 5.25% a year ago. Sequentially PAT rose 25.0% QoQ from Q1 FY27's ₹335.73 Cr, but that was flattered by a ₹10.78 Cr net tax credit rather than operating improvement — operating margin (PBT + depreciation + finance cost − other income, over revenue) actually fell further to 3.76% from 4.79% in Q1 and 5.63% a year ago, a second straight quarter of compression. No exceptional items were booked in either period, so this is an underlying decline, not a one-off-driven swing.
Q2 FY-2027 vs prior quarters
By segment, Edible Oils revenue grew 22.4% YoY to ₹8,532.25 Cr but segment profit grew only 7.5% YoY to ₹223.39 Cr (from ₹207.76 Cr) — strong volumes/pricing didn't convert to proportional profit, consistent with cost pass-through lag on crude edible-oil prices. FMCG, the segment management has pitched as the premiumisation growth driver, was essentially flat YoY (+0.3%) at ₹2,923.48 Cr, and its segment profit fell 39.1% YoY to ₹207.90 Cr from ₹341.63 Cr.
The stock went into the print at ₹421, up 14.2% over the past month of trading.
What the summary numbers don't show
EPS (basic) ₹3.86, up from ₹3.09 in Q1 FY27 but down from ₹4.75 a year ago
No exceptional items in current or year-ago quarter — auditor issued unmodified review opinion on both standalone and consolidated statements
Reaffirmed FY27 full-year: Foods 8-10% growth, HPC 15%, edible oils 3-4% volume, FMCG EBITDA margin growth 12-15%, overall EBITDA margin target 10-12% growth. Long-term target ₹2,500 Cr annualized EBITDA within 18 months via oil palm, HPC mix, edible oils margin expansion.
— This quarter: missed
This print runs well behind the FY27 guidance management reaffirmed as of the Q1 FY27 concall (24 Aug 2026) — Foods growth 8-10%, HPC 15%, edible oil volume 3-4%, FMCG EBITDA margin growth 12-15%, and overall EBITDA growth 10-12%: this quarter's operating EBITDA actually fell ~22.9% YoY to ₹425.60 Cr from ₹552.09 Cr, the opposite direction of the margin-growth target, and FMCG's flat topline is well short of the 8-10%/15% ask. No verified Street/consensus estimate specific to this quarter was found in public previews, so the comparison to consensus is marked unknown rather than assumed; management's own press release for this result was also not available to cross-check its framing. On the corporate side, the quarter carried a food-safety prohibition/recall order on a Cow Ghee batch (24-29 Oct 2026) and an earlier Sunrich edible-oil batch ban (21 Sep 2026), alongside an ESG rating of 59 (core 66, 14 Oct 2026) and a reported push into digital/institutional channels (6 Nov 2026) — none of these show up as separately quantified items in the results, but the regulatory actions sit uncomfortably next to a quarter where FMCG, the segment carrying the brand-sensitive packaged-foods and HPC lines, already stalled.
W1
FMCG segment revenue growth vs the 8-10%/15% HPC guidance — flat YoY this quarter at ₹2,923.48 Cr, watch for Q3 reacceleration
W2
Operating margin trend — 3.76% this quarter vs 4.79% (Q1 FY27) and 5.63% (Q2 FY26); a third straight quarterly decline would confirm a margin problem against FY27's 10-12% EBITDA growth guidance
W3
Edible Oils profit-to-revenue gap — revenue +22.4% YoY vs segment profit +7.5% YoY; watch whether cost pass-through narrows this gap next quarter
Converted from ₹ Lakh to ₹ Crore; standalone and consolidated are near-identical as only two small subsidiaries (combined assets ~₹104 Cr, nil revenue) and a beneficiary trust are consolidated. Tax line is a net credit of ₹10.78 Cr — current tax ₹119.02 Cr and deferred tax credit ₹14.50 Cr offset by a ₹115.31 Cr write-back for tax related to earlier years. No exceptional items in current or year-ago quarter, so YoY PAT decline needs no one-off adjustment.
Momentum under pressure: Q2 to test margin defence amid regulatory headwinds
Patanjali Foods enters Q2 results on the back of a record Q1, but faces tactical headwinds. The Street watches for revenue pace moderation, margin resilience, and whether e-commerce gains offset regulatory friction.
Patanjali Foods reports Q2 results on November 14, fresh off a record Q1 (+29% revenue, +86% PAT). The Street's focus: can management defend margins while moderating revenue pace toward the 12–15% FY27 guidance band? Two competing narratives frame the setup—the bull case sees FMCG (now 26% of revenue, +35% in Q1) as a durable acceleration engine offsetting oil-segment headwinds; the bear case worries that regulatory friction on specific ghee and oil batches presages larger brand/execution risk, compounded by a technically overbought setup and FII outflows over the past year.
~₹12,000–12,500 Cr
Implies 20–25% YoY growth; Q1 was ₹11,337.5 Cr at +29%. Moderation toward guidance is normal; watch for segment splits.
~4.5–5.2%
Q1 was 4.80%. Input cost trends (oils, packaging) will be critical; guidance on FY27 margin trajectory overdue.
~28–32% YoY
Q1 FMCG revenue ₹2,938 Cr (+35% YoY). If Q2 sustains 28%+, FMCG becomes the credible growth bridge; at 15%+ it may signal slowdown.
~₹8,200–8,700 Cr
Q1 was ₹8,505 Cr. Mustard-oil demand seasonal; any guidance on volume/pricing for H2 FY27 will reset expectations.
A strong Q2 print would show: revenue ₹12,300+ Cr (24%+ YoY), EBITDA margin 4.8%+, FMCG revenue >₹2,900 Cr (+30%+ YoY), and management sticking to the 12–15% FY27 guidance with confidence. A weak print would deliver: revenue ₹11,800 Cr or below (17–19% YoY), EBITDA margin below 4.5%, FMCG plateau or miss (under 25% growth), or any commentary on regulatory headwinds materially damaging brand equity or Q3/Q4 run-rates.
On track to FY27 guidance?
Yes—so far. Q1 alone (₹11,337.5 Cr revenue at +29% PAT) puts the company ahead of the 12–15% growth band, but FY growth is a blended number; seasonality matters. The real test: is Q1 an outlier or the new floor? If Q2 shows 22%+ growth, the market will upgrade FY27 targets; if Q2 drops below 18%, consensus shifts to a cautious mode. Guidance reiterated by management in the Q1 call (Foods 8–10%, HPC 15%, Oils 2–4%, consolidated 12–15%) remains in play, but Q2 delivery will either affirm or force a revision.
What's changed since Q1 (Aug 14 results)?
1 · E-commerce breakthrough (Nov 6 update)
Management announced that digital and quick-commerce channels now represent ~35% of group turnover—a major shift toward DTC and B2B institutional sales. This is the growth story the Street wants to see; the Q2 call will be scrutinized for breakouts by channel and margin implications of e-commerce mix.
2 · Regulatory friction: Cow Ghee & Sunflower Oil batches (Oct 24–29, Nov 3)
Three regulatory actions in as many weeks: recall order for a Cow Ghee batch (Burhanpur, Oct 21) and prohibition orders for Sunrich Sunflower Oil batch (Thiruvananthapuram, Sept 15) and another Cow Ghee batch (Chhindwara, Oct 16). Company is filing appeals and characterizing these as isolated to specific batches/distributors, with no nationwide impact. The Street consensus: isolated, but watch for a pattern or brand-equity dent in Q2 commentary. No material financial impact disclosed, but management credibility will hinge on the tone.
3 · Interim dividend payouts (Aug 18, Aug 14)
Board declared 1st interim dividend ₹0.80 (announced Aug 14) and 3rd interim for FY26 (₹1.00). Total interim for FY27 so far: ₹0.80. Signaling capital return confidence; watch for 2nd/3rd interim interim declaration post-Q2 (precedent exists).
4 · Valuation & technical setup (neutral-to-cautionary)
Stock at ₹431 is 35.7% off ATH (₹670), RSI at 75.5 (overbought). SMA20 ₹381, SMA50 ₹370, SMA200 ₹423—price is above all three. Volume normal. FII ownership erosion (8.53% vs 12.99% YoY) and GQG partial exit signal tactical profit-taking in the last 12 months. Q2 beat would likely be priced in; a miss or margin cut could trigger a sharp reversion.
Watch list for result day (Nov 14)
1 · Segment revenue split & FMCG run-rate
Is FMCG >₹2,900 Cr (30%+ growth)? Is e-commerce breakout material and profitable? If FMCG slips below 25% growth or e-commerce margins are compressed, the narrative shifts to 'momentum plateauing.' Oils and HPC trends matter too; weakness in HPC (target 15%) would be a yellow flag.
2 · EBITDA margin & FY27 guidance reaffirmation
Sub-4.5% margin would disappoint. Management's commentary on cost inflation (edible oils, packaging) and pricing power will reset investor expectations for H2 FY27. Any downgrade to the 12–15% guidance band would likely trigger a selloff in a overbought setup.
3 · Regulatory Q&A and tone on brand health
Expect pushback on the three recent regulatory actions. The Street will listen for: (a) root-cause analysis (supplier, process, quality gate?), (b) customer/distributor impact, and (c) assurance that Q3/Q4 won't see fresh orders. Any hint of systemic issues could spark a repricing regardless of Q2 headline beat.
Patanjali Foods goes into Q2 results as a company that has delivered a record first quarter and reiterated bullish FY27 guidance, but faces two tactical headwinds: regulatory friction on isolated batches (signaling QA vulnerabilities the Street will probe) and a technically overbought setup with FII ownership retreating. The consensus case—revenue in the ₹12,000–12,500 Cr band, FMCG momentum intact, and margins defended—is achievable and would likely hold the stock in a ₹430–480 range near-term. A beat (revenue ₹12,500+, FMCG >32%, margin 5%+) could reignite FII interest and support a move toward ₹500–520; a miss or margin surprise would likely trigger a sharp 10–15% pullback to ₹370–390 given the overbought technicals and recent insider/FII outflows.
Result date: November 14, 2026. Board meets at 3:00 PM IST.